Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1626 1628 1657 1672
This examiner grants 73% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18591138 | CARBON DIOXIDE ADSORBENT AND CARBON DIOXIDE ADSORPTION-DESORPTION DEVICE | Non-Final OA | KABUSHIKI KAISHA TOSHIBA |
| 17712527 | PHARMACEUTICAL COMPOSITION AND KIT CONTAINING NOVEL PENAM DERIVATIVE OR SALT THEREOF AND ONE OR MORE COMPOUNDS SELECTED FROM beta-LACTAMASE INHIBITORY COMPOUND AND ANTIBACTERIAL COMPOUND OR SALTS THEREOF | Final Rejection | FUJIFILM Corporation |
| 18550996 | NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 | Final Rejection | Vanderbilt University |
| 17522171 | PRESERVATIVE CONTAINING COMPOSITIONS | Non-Final OA | Kenvue Brands LLC |
| 17252771 | COMPOSITION COMPRISING FLT3 INHIBITOR AS EFFECTIVE INGREDIENT FOR INHIBITING DRUG RESISTANCE IN CHRONIC MYELOGENOUS LEUKEMIA | Final Rejection | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 17659274 | TREATING NEURAL DISEASE WITH TYROSINE KINASE INHIBITORS | Final Rejection | GEORGETOWN UNIVERSITY |
| 17059761 | COMPOSITIONS AND METHODS FOR OPIOID OVERDOSE RESCUE | Final Rejection | Purdue Pharma L.P. |
| 17820692 | REMITTIVE EFFECTS OF TAPINAROF IN THE TREATMENT OF PLAQUE PSORIASIS, ATOPIC DERMATITIS, OR RADIATION DERMATITIS | Non-Final OA | Dermavant Sciences GmbH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy